Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 20 December 2025

Boeing Stock News Today (Dec. 20, 2025): BA Holds Near $214 as Wall Street Bets on a 2026 Cash-Flow Turnaround

Boeing Stock News Today (Dec. 20, 2025): BA Holds Near $214 as Wall Street Bets on a 2026 Cash-Flow Turnaround

Boeing Stock News Today (Dec. 20, 2025): BA Holds Near $214 as Wall Street Bets on a 2026 Cash-Flow Turnaround Boeing (NYSE: BA) enters the weekend with momentum—and with investors laser-focused on whether 2026 becomes the year the company finally turns operational progress into durable cash generation. Because U.S. markets are closed on Saturday, December 20, 2025, the latest tape for Boeing stock is Friday’s close: $214.08, up 2.79% on the session. MarketWatchThat move mattered beyond Boeing’s chart: a strong Boeing session was one of the notable contributors to the Dow’s advance on December 19. MarketWatch What makes Boeing stock
20 December 2025
·
Chevron Stock (CVX) News Today, Dec. 20, 2025: Venezuela Blockade Risk, Guyana Growth, and 2026 Buyback Outlook

Chevron Stock (CVX) News Today, Dec. 20, 2025: Venezuela Blockade Risk, Guyana Growth, and 2026 Buyback Outlook

December 20, 2025 — Chevron Corporation (NYSE: CVX) is heading into year-end with investors balancing two powerful forces: geopolitical volatility (especially around Venezuela) and big, company-specific catalysts tied to Guyana, disciplined capital spending, and shareholder returns. Chevron stock last traded around $147.75, essentially flat versus the prior close, after Friday’s session (U.S. markets are closed today). Below is a detailed roundup of the most important CVX stock news, forecasts, and analyses shaping the outlook as of Dec. 20, 2025—and the key signposts investors are watching into early 2026. Why Chevron stock is in focus on Dec. 20, 2025 Chevron’s narrative
20 December 2025
···
IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

IBM Stock News and Forecast for 2026: IBM Shares Hold Near $301 as Confluent Deal, Credit Outlook, and Analyst Calls Collide (Dec. 20, 2025)

International Business Machines Corporation (NYSE: IBM) enters the final stretch of 2025 with its stock consolidating near the $300 level—an area that has become a focal point for both bulls betting on IBM’s “AI + hybrid cloud” strategy and skeptics warning that the company’s acquisition push could strain the balance sheet. IBM stock last closed at $300.98 on Friday, Dec. 19, 2025, up about 0.18% on the day. With U.S. markets closed on Saturday, Dec. 20, that close is the latest reference point for investors tracking the name into year-end. StockAnalysis What’s driving the debate right now is a tight
20 December 2025
···
Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

Insmed (INSM) Stock News and Forecasts on Dec. 20, 2025: Brinsupri Trial Miss, Truist Upgrade, and Updated Price Targets

December 20, 2025 — Insmed Incorporated (NASDAQ: INSM) is ending the week in “re-pricing mode” after a mid-stage clinical setback jolted investor expectations, sparked sharp volatility, and triggered a round of analyst price-target revisions. By Friday’s close (the last U.S. trading session before today’s Saturday), Insmed shares finished at $174.84, up about 5% on the day—recovering some ground after Thursday’s steep drop. The catalyst remains the same: Insmed disclosed that its Phase 2b BiRCh study of brensocatib (brand: Brinsupri) in chronic rhinosinusitis without nasal polyps (CRSsNP)missed both primary and secondary efficacy endpoints, prompting the company to discontinue that indication. At
20 December 2025
··
Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood (HOOD) Stock News, Forecasts and Analysis as of Dec. 20, 2025: Prediction Markets, AI “Cortex,” and Global Expansion Take Center Stage

Robinhood Markets, Inc. (NASDAQ: HOOD) is closing out mid-December with investor attention locked on a single theme: the company’s rapid shift from a “commission-free broker” into a broader trading-and-betting marketplace, powered by prediction markets, expanding crypto capabilities, and new international growth bets. HOOD last traded around $121.35 (based on the latest U.S. market close), giving Robinhood a market value of roughly $127 billion and putting the stock well off its 52-week high near $153.86 after one of its strongest years since going public. StockAnalysis What’s different right now isn’t just the share price—it’s what investors believe Robinhood is becoming. In
20 December 2025
·
lululemon athletica inc. Stock (LULU): Elliott’s $1B Stake, CEO Transition, Buybacks, and Wall Street’s 2026 Outlook (As of Dec. 20, 2025)

lululemon athletica inc. Stock (LULU): Elliott’s $1B Stake, CEO Transition, Buybacks, and Wall Street’s 2026 Outlook (As of Dec. 20, 2025)

lululemon athletica inc. (NASDAQ: LULU) is closing out the week of Dec. 20, 2025 with a rare combination of catalysts that can move a stock fast: a CEO exit and succession search, better-than-expected quarterly results, an expanded buyback authorization, and a reported $1+ billion activist stake from Elliott Investment Management. The headlines helped reignite trading interest in LULU stock—but they also underscored why the shares have struggled through 2025: slowing momentum in the Americas, margin pressure tied to promotions and costs, and intensifying competition in athleisure. The debate for investors now is whether leadership change plus activist involvement can accelerate
20 December 2025
·
Texas Instruments Stock (NASDAQ: TXN) on Dec. 20, 2025: Sherman Fab Starts Production, Analysts Split on the 2026 Outlook

Texas Instruments Stock (NASDAQ: TXN) on Dec. 20, 2025: Sherman Fab Starts Production, Analysts Split on the 2026 Outlook

December 20, 2025 Texas Instruments Incorporated (NASDAQ: TXN) heads into the weekend at the center of two narratives that rarely collide so neatly: a major U.S. manufacturing milestone and a fresh wave of Wall Street debate about what that investment means for margins, cash flow, and share performance in the next semiconductor cycle. TXN last closed at $176.29 (Dec. 19, 2025), with trading in recent sessions reflecting investor tug-of-war between long-term capacity advantages and short-term profitability concerns. StockAnalysis Below is a full roundup of the current news, forecasts, and analyses relevant to Texas Instruments stock as of 20.12.2025, plus the
20 December 2025
··
T-Mobile (TMUS) Stock News and Forecasts on Dec. 20, 2025: Buybacks, Dividend Momentum, Analyst Targets, and 2026 Catalysts

T-Mobile (TMUS) Stock News and Forecasts on Dec. 20, 2025: Buybacks, Dividend Momentum, Analyst Targets, and 2026 Catalysts

December 20, 2025 — T-Mobile US, Inc. (NASDAQ: TMUS) enters the final stretch of 2025 with investors balancing two competing narratives: a company leaning hard into shareholder returns (buybacks and a growing dividend), and a U.S. wireless market that looks increasingly promotional and maturity-driven. With U.S. markets closed today (Saturday), the most recent trading session was Friday, December 19. TMUS closed at $196.73, down 1.77% on the day, and has pulled back sharply from its $276.49 52‑week high set on March 3, 2025—a decline of roughly 29% from that peak. Volume on Friday was notably elevated versus recent norms, adding
20 December 2025
·
UnitedHealth Group Incorporated (UNH) Stock: Latest News, Forecasts, and Analysis for December 20, 2025

UnitedHealth Group Incorporated (UNH) Stock: Latest News, Forecasts, and Analysis for December 20, 2025

Updated: Dec. 20, 2025 UnitedHealth Group Incorporated (NYSE: UNH) heads into the weekend with investors weighing two powerful storylines: fresh political pressure on health insurance premiums and a company-led operational overhaul sparked by outside audits. The stock last closed at $327.42 on Friday, Dec. 19, down 0.22% on the day. It’s down about 33% over the past 12 months and down roughly 34% year-to-date, though it’s up modestly over the past month—a sign that bargain-hunters are starting to test the waters after a bruising 2025 for managed-care names. Finance Charts Below is a complete, publication-ready breakdown of the current UNH
20 December 2025
·
Warner Bros. Discovery (WBD) Stock Forecast and News Today: Netflix Merger Terms, Paramount’s $30 Bid, and What Investors Are Watching (Dec. 20, 2025)

Warner Bros. Discovery (WBD) Stock Forecast and News Today: Netflix Merger Terms, Paramount’s $30 Bid, and What Investors Are Watching (Dec. 20, 2025)

Updated: December 20, 2025 Warner Bros. Discovery, Inc. “Series A” stock (NASDAQ: WBD) is no longer trading like a typical media equity. As of this weekend, the share price is behaving more like a deal-driven instrument—pulled between Netflix’s signed cash-and-stock acquisition of WBD’s Streaming & Studios business and Paramount Skydance’s hostile all-cash bid for the entire company. Netflix+2Reuters+2 For investors, the question isn’t just “Is WBD undervalued?” It’s: Which transaction path is most likely to close—and what is each path really worth after fees, timing, and risk? Here’s the full, up-to-date picture as of December 20, 2025, including the key
20 December 2025
···
Rocket Lab Stock (RKLB) Surges After $805M–$816M SDA Satellite Deal: Latest News, Analyst Forecasts, and 2026 Outlook

Rocket Lab Stock (RKLB) Surges After $805M–$816M SDA Satellite Deal: Latest News, Analyst Forecasts, and 2026 Outlook

December 20, 2025 — Rocket Lab Corporation (NASDAQ: RKLB) is closing out 2025 with a catalyst that investors have been waiting for: a major U.S. Space Development Agency (SDA) award that further cements the company’s shift from “small-launch specialist” to vertically integrated national-security space prime. Shares surged to a record close of $70.52 on Friday, December 19, after the contract news hit, capping a volatile but powerful year for the stock. MarketWatch What follows is a full, up-to-date breakdown of the news driving Rocket Lab stock, the contract details, the latest financial guidance, and the most current analyst forecasts and
20 December 2025
·····
ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow, Inc. (NYSE: NOW) heads into the weekend with investors still digesting one of the most turbulent stretches the enterprise software leader has seen this year: a fresh stock split, a confirmed AI acquisition closing, and intense market debate over whether a rumored $7 billion cybersecurity deal would be a smart strategic leap—or an expensive distraction. As of Saturday, Dec. 20, 2025, U.S. markets are closed. The most recent session (Friday, Dec. 19) ended with ServiceNow shares at $155.31, up 1.26% on the day, with trading volume jumping to roughly 25.1 million shares—far above recent averages. StockAnalysis+1 That modest Friday
20 December 2025
···
Bank of America (BAC) Stock News Today: Analyst Price Targets, Q4 Earnings Preview, and What Could Move Shares in 2026

Bank of America (BAC) Stock News Today: Analyst Price Targets, Q4 Earnings Preview, and What Could Move Shares in 2026

December 20, 2025 — Bank of America Corporation (NYSE: BAC) is closing out the year with its stock near a 52-week high, supported by a late-2025 tailwind from improving capital markets activity and fresh signals from management about fourth-quarter momentum. With U.S. markets closed for the weekend, investors are now looking ahead to the bank’s next earnings report and what the Federal Reserve’s latest rate cut could mean for 2026 profitability. Below is a comprehensive roundup of the latest BAC stock news, forecasts, and analyst views as of Dec. 20, 2025. BAC stock price today: Where Bank of America shares
20 December 2025
··
Mastercard (MA) Stock News, Forecasts and Analyst Outlook: What Investors Are Watching on December 20, 2025

Mastercard (MA) Stock News, Forecasts and Analyst Outlook: What Investors Are Watching on December 20, 2025

December 20, 2025 — Mastercard Incorporated (NYSE: MA) heads into the final stretch of 2025 with its stock sitting near record territory and investors weighing a familiar mix of catalysts: resilient consumer spending, accelerating “services” growth, a fresh multi‑billion‑dollar buyback authorization, and a pair of closely watched legal battles that could reshape parts of the U.S. payments-fee landscape. As of the latest close (Friday, December 19, 2025), Mastercard shares finished at $572.23 (up 1.06% on the day) with a modest after-hours move to $572.65. StockAnalysis Below is the complete, up-to-date snapshot of Mastercard stock news, forecasts, and current analysis that
20 December 2025
·
Goldman Sachs Stock (NYSE: GS): Latest News, Analyst Forecasts, and 2026 Outlook as of December 20, 2025

Goldman Sachs Stock (NYSE: GS): Latest News, Analyst Forecasts, and 2026 Outlook as of December 20, 2025

NEW YORK — December 20, 2025 — Goldman Sachs Group, Inc. (NYSE: GS) is closing out 2025 with momentum: a strong year for big banks, a revived deal pipeline, and fresh headlines that reinforce the firm’s push deeper into AI-driven infrastructure, software dealmaking, and active ETFs. But with GS trading near its highs, the stock debate is shifting from “recovery” to “valuation and sustainability.” Below is a comprehensive roundup of the most relevant GS stock news, forecasts, and market analysis available as of 20.12.2025, plus what investors are watching next. Goldman Sachs stock price today: where GS stands heading into
20 December 2025
·
AbbVie Stock (ABBV) News Today: Drug-Pricing Deal Watch, Skyrizi/Rinvoq Momentum, and Fresh Wall Street Forecasts (Dec. 20, 2025)

AbbVie Stock (ABBV) News Today: Drug-Pricing Deal Watch, Skyrizi/Rinvoq Momentum, and Fresh Wall Street Forecasts (Dec. 20, 2025)

December 20, 2025 — AbbVie Inc. (NYSE: ABBV) is closing out the week in the spotlight as U.S. drug-pricing policy headlines collide with a still-strong “post-Humira” growth narrative built around Skyrizi and Rinvoq. The stock finished the last regular session (Friday, Dec. 19) at $226.82, up 1.80%, while trading volume surged well above its recent average — a sign that investors were repositioning into large-cap pharma after a rapid sequence of Washington announcements. MarketWatch Below is a full roundup of what’s driving AbbVie stock right now (as of 20.12.2025), what analysts are forecasting, and which catalysts could matter most heading
20 December 2025
·
Utilities Stocks Outlook for 2026: AI Data Center Demand, Rate Cuts, and the New Power-Grid Investment Cycle

Utilities Stocks Outlook for 2026: AI Data Center Demand, Rate Cuts, and the New Power-Grid Investment Cycle

Dec. 20, 2025 Utilities stocks are having a moment that would’ve been hard to imagine just a few years ago. The sector long known for predictable dividends and regulated earnings is now being pulled into the center of the AI buildout—because none of it runs without electricity. As of Dec. 20, 2025, the utilities story is no longer just “bond-proxy, defensive, yield.” It’s increasingly about load growth, grid reliability, data centers, and a multi-year capital spending wave—with investors trying to decide whether the sector’s recent pullback is a warning sign or an entry point. Below is a detailed roundup of
20 December 2025
········
Financial Services Stocks Outlook (Dec. 20, 2025): Banks, Payments, and Insurers Face 2026 Crosscurrents as Rates Shift and Stablecoins Go Mainstream

Financial Services Stocks Outlook (Dec. 20, 2025): Banks, Payments, and Insurers Face 2026 Crosscurrents as Rates Shift and Stablecoins Go Mainstream

Financial services stocks are heading into the final stretch of 2025 with momentum—but also with a more complicated 2026 narrative than “higher rates = higher bank earnings.” The week ending Friday, December 19, 2025 delivered a dense mix of signals for investors in bank stocks, payments names, brokers/exchanges, and insurers: central banks are hinting the global rate-cut cycle is cooling (or pausing), dealmaking is strong enough to lift compensation and hiring plans, stablecoins are moving from “pilot” to “plumbing,” and policy risk is reasserting itself in healthcare coverage and insurance pricing. Reuters+3Reuters+3Reuters+3 Below is a comprehensive, publication-ready roundup of the
20 December 2025
·
Industrials Stocks Today: Latest Sector News, 2026 Forecasts, and Key Catalysts to Watch (Dec. 20, 2025)

Industrials Stocks Today: Latest Sector News, 2026 Forecasts, and Key Catalysts to Watch (Dec. 20, 2025)

Industrials stocks are closing out 2025 with something they haven’t consistently enjoyed in recent years: a credible claim to market leadership that isn’t purely “late-cycle” or “reopening” nostalgia. Heading into 2026, investors are increasingly framing the industrials sector as a bridge between two powerful forces shaping the next market phase—an AI-driven capital spending cycle and a policy-and-infrastructure push that’s reshaping supply chains, defense priorities, and freight networks. The timing matters. As of Saturday, December 20, 2025, the most recent U.S. trading session was Friday’s close, when major indexes finished the week higher and remained solidly positive for the year—helping keep
20 December 2025
·
Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

Healthcare Stocks News Today: Drug Pricing Shake-Up, Biotech M&A, IPO Momentum, and 2026 Outlook (Dec. 20, 2025)

As of December 20, 2025, healthcare stocks are heading into year-end with a rare mix of policy clarity and policy risk—often at the same time. In the past 48 hours, the sector has been hit by major U.S. drug-pricing announcements, renewed focus on insurance premiums, and a fresh run of deal and IPO headlines that are reshaping investor expectations for 2026. Reuters+3Reuters+3Reuters+3 Below is a comprehensive roundup of the most market-moving healthcare news, plus the latest forecasts and sector analysis shaping how investors are positioning across pharma, biotech, managed care, medtech, and healthcare services into 2026. 1) Drug pricing is
20 December 2025
········
1 … 688 689 690 691 692 … 1,170

Stock Market Today

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

Walmart stock jumps 3% to $131 as Dow clears 50,000 — what to watch before Monday

7 February 2026
Walmart shares climbed 3.34% to $131.18 Friday, pushing its market value to about $1.05 trillion as the Dow closed above 50,000 for the first time. Retail stocks mostly gained, with Target up 4.24% and Costco up 1.20%, while Amazon dropped 5.55%. Investors await Walmart’s fiscal Q4 results on Feb. 19 and key U.S. economic data next week.
Go toTop